The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control

Primary cultures of hepatocytes are powerful models in studying the sequence of events that are necessary for cell progression from a G0-like state to S phase. The models mimic the physiological process of hepatic regeneration after liver injury or partial hepatectomy. Many reports suggest that the...

Full description

Saved in:
Bibliographic Details
Main Authors: Jean-Philippe Guégan, Christophe Frémin, Georges Baffet
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:International Journal of Hepatology
Online Access:http://dx.doi.org/10.1155/2012/328372
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566581311307776
author Jean-Philippe Guégan
Christophe Frémin
Georges Baffet
author_facet Jean-Philippe Guégan
Christophe Frémin
Georges Baffet
author_sort Jean-Philippe Guégan
collection DOAJ
description Primary cultures of hepatocytes are powerful models in studying the sequence of events that are necessary for cell progression from a G0-like state to S phase. The models mimic the physiological process of hepatic regeneration after liver injury or partial hepatectomy. Many reports suggest that the mitogen-activated protein kinase (MAPK) ERK1/2 can support hepatocyte proliferation in vitro and in vivo and the MEK/ERK cascade acts as an essential element in hepatocyte responses induced by the EGF. Moreover, its disregulation has been associated with the promotion of tumor cell growth of a variety of tumors, including hepatocellular carcinoma. Whereas the strict specificity of action of ERK1 and ERK2 is still debated, the MAPKs may have specific biological functions under certain contexts and according to the differentiation status of the cells, notably hepatocytes. In this paper, we will focus on MEK1/2-ERK1/2 activations and roles in normal rodent hepatocytes in vitro and in vivo after partial hepatectomy and in human hepatocarcinoma cells. The possible specificity of ERK1 and ERK2 in normal and transformed hepatocyte will be discussed in regard to other differentiated and undifferentiated cellular models.
format Article
id doaj-art-e77fd99b08dc4145b999b94812107268
institution Kabale University
issn 2090-3448
2090-3456
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series International Journal of Hepatology
spelling doaj-art-e77fd99b08dc4145b999b948121072682025-02-03T01:03:46ZengWileyInternational Journal of Hepatology2090-34482090-34562012-01-01201210.1155/2012/328372328372The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle ControlJean-Philippe Guégan0Christophe Frémin1Georges Baffet2Inserm, U1085, Institut de Recherche sur la Santé l’Environnement et le Travail (IRSET), Université de Rennes 1, SFR Biosit, 35043 Rennes, FranceInserm, U1085, Institut de Recherche sur la Santé l’Environnement et le Travail (IRSET), Université de Rennes 1, SFR Biosit, 35043 Rennes, FranceInserm, U1085, Institut de Recherche sur la Santé l’Environnement et le Travail (IRSET), Université de Rennes 1, SFR Biosit, 35043 Rennes, FrancePrimary cultures of hepatocytes are powerful models in studying the sequence of events that are necessary for cell progression from a G0-like state to S phase. The models mimic the physiological process of hepatic regeneration after liver injury or partial hepatectomy. Many reports suggest that the mitogen-activated protein kinase (MAPK) ERK1/2 can support hepatocyte proliferation in vitro and in vivo and the MEK/ERK cascade acts as an essential element in hepatocyte responses induced by the EGF. Moreover, its disregulation has been associated with the promotion of tumor cell growth of a variety of tumors, including hepatocellular carcinoma. Whereas the strict specificity of action of ERK1 and ERK2 is still debated, the MAPKs may have specific biological functions under certain contexts and according to the differentiation status of the cells, notably hepatocytes. In this paper, we will focus on MEK1/2-ERK1/2 activations and roles in normal rodent hepatocytes in vitro and in vivo after partial hepatectomy and in human hepatocarcinoma cells. The possible specificity of ERK1 and ERK2 in normal and transformed hepatocyte will be discussed in regard to other differentiated and undifferentiated cellular models.http://dx.doi.org/10.1155/2012/328372
spellingShingle Jean-Philippe Guégan
Christophe Frémin
Georges Baffet
The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control
International Journal of Hepatology
title The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control
title_full The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control
title_fullStr The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control
title_full_unstemmed The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control
title_short The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control
title_sort mapk mek1 2 erk1 2 pathway and its implication in hepatocyte cell cycle control
url http://dx.doi.org/10.1155/2012/328372
work_keys_str_mv AT jeanphilippeguegan themapkmek12erk12pathwayanditsimplicationinhepatocytecellcyclecontrol
AT christophefremin themapkmek12erk12pathwayanditsimplicationinhepatocytecellcyclecontrol
AT georgesbaffet themapkmek12erk12pathwayanditsimplicationinhepatocytecellcyclecontrol
AT jeanphilippeguegan mapkmek12erk12pathwayanditsimplicationinhepatocytecellcyclecontrol
AT christophefremin mapkmek12erk12pathwayanditsimplicationinhepatocytecellcyclecontrol
AT georgesbaffet mapkmek12erk12pathwayanditsimplicationinhepatocytecellcyclecontrol